IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Citichem India IPO is a book build IPO listing on BSE SME exchange. The company is based in Mumbai and caters to Chemical sector. Horizon Management Private is the merchant banker of Citichem India IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 24th June 2024.
Citichem India IPO posted revenues of Rs 5.96 crores and PAT of Rs 0.80 crores in FY25 on annualised basis.Financial results of Citichem India IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Citichem India IPO PAT Margin is 18.18%, ROCE (Return on Capital Employed) is 3.30% as per latest financial. The below table shows Citichem India IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Citichem India IPO is Rs 47.60 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Citichem India IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Citichem India IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Citichem India IPO is ₹47.60 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Citichem India IPO has a Price-to-Earnings (PE) ratio of 59.65 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Citichem India IPO reported revenue of ₹5.96 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Citichem India IPO provide insights into sales growth, market demand, and business scalability.
Citichem India recorded an EBITDA of ₹ 1.12 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Citichem India Profit After Tax (PAT) is ₹0.80 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 4.40 Cr.
EBITDA Margin:
25.45
%
Net Worth: ₹ 7.45 Cr.
Market Capitalisation:
₹ 47.60 Cr.
P/E:
59.65 times
P/BV: 2.37 times
EV/EBITDA: 43.32 times
Citichem India operates in Chemical and Supply Organic/inorganic Chemicals, Bulk Drugs, Food Chemicals, Pharmaceuticals, Etc.. The Issue is listed on BSE SME in Jan, 2025. Citichem India IPO size was 12.60 with Issue price of 70.00 .
Merchant Banker(s) of Citichem India IPO: Horizon Management Private Limited
Citichem India IPO subscription was 414.35 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Citichem India IPO listed at a listing price of 68.28 against the offer price of 70.00.
The current market price of Citichem India is 28.27.
Why Us?
